Y

Yili Chuanning Biotechnology Co Ltd
SZSE:301301

Watchlist Manager
Yili Chuanning Biotechnology Co Ltd
SZSE:301301
Watchlist
Price: 14.14 CNY -3.81% Market Closed
Market Cap: 31.4B CNY
Have any thoughts about
Yili Chuanning Biotechnology Co Ltd?
Write Note

Net Margin
Yili Chuanning Biotechnology Co Ltd

23.5%
Current
20%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
23.5%
=
Net Income
1.3B
/
Revenue
5.6B

Net Margin Across Competitors

Country CN
Market Cap 31.5B CNY
Net Margin
23%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 300.2B USD
Net Margin
9%
Country US
Market Cap 158.7B USD
Net Margin
13%
Country US
Market Cap 126.8B USD
Net Margin
-5%
Country US
Market Cap 115B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 137.3B AUD
Net Margin
18%
Country US
Market Cap 88.3B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Yili Chuanning Biotechnology Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
23.5%
=
Net Income
1.3B
/
Revenue
5.6B
What is the Net Margin of Yili Chuanning Biotechnology Co Ltd?

Based on Yili Chuanning Biotechnology Co Ltd's most recent financial statements, the company has Net Margin of 23.5%.